Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimal Insulin Correction in Post-Exercise Hyperglycemia (FIT)
NCT03057470Phase 4Unknown
- Sponsor
- LMC Diabetes & Endocrinology
- Start
- May 2016
- Primary completion
- Mar 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of human insulin in type 1 diabetes mellitus (T1D), sponsored by LMC Diabetes & Endocrinology. Status: unknown.
02
Drugs
human insulin
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT03057470.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03057470.